SCHEMBL8429166

SCHEMBL8429166

NN=CNc1cccc(C(=O)C(N)(C(=O)O)S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.43
CA2 P00918 6/20 0.43
CA4 P22748 2/20 0.43
PFKFB3 Q16875 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
F2 P00734 1/20 0.36
TMPRSS6 Q8IU80 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CA9 Q16790 3/20 0.36
CA12 O43570 2/20 0.36
MAPT P10636 2/20 0.35
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8693780 0.83 CA1 (0.39) CA1CA2CA4PFKFB3MEN1
SCHEMBL8694027 0.82 CA1 (0.38) CA1CA2CA4PFKFB3MEN1
SCHEMBL8429109 0.77 MEN1 (0.37) CA1CA2CA4MEN1KMT2A
SCHEMBL8697026 0.76 CA1 (0.40) CA1CA2CA4MEN1KMT2A
SCHEMBL8431264 0.75 CA1 (0.36) CA1CA2CA4MEN1KMT2A
SCHEMBL6777725 0.75 RAB9A (0.50) CA1CA2PFKFB3MEN1KMT2A
SCHEMBL8538572 0.73 KMT2A (0.36) CA1CA2CA4MEN1KMT2A
SCHEMBL8432297 0.73 RAB9A (0.43) MEN1KMT2AALDH1A1SMN1; SMN2F2
SCHEMBL8429467 0.70 CYP1A2 (0.41) CA1CA2CA4PFKFB3MEN1
SCHEMBL8432262 0.70 ERCC5 (0.38) CA1CA2CA4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952381-A SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS G. D. SEARLE & CO. (US) 1999-09-14 US disclosed